Article Details

Synlogic Presents Data Demonstrating Activity of a Solid Oral Formulation of SYNB1618 at ...

Retrieved on: 2021-04-13 13:18:45

Tags for this article:

Click the tags to see associated articles and topics

Synlogic Presents Data Demonstrating Activity of a Solid Oral Formulation of SYNB1618 at .... View article details on hiswai:

Excerpt

CAMBRIDGE, Mass., April 13, 2021 Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up